iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.
Exp Cell Res
; 412(1): 113007, 2022 03 01.
Article
in En
| MEDLINE
| ID: mdl-34990619
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mucopolysaccharidosis II
/
Induced Pluripotent Stem Cells
/
Neural Stem Cells
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Exp Cell Res
Year:
2022
Type:
Article